Testosterone is an important male hormone produced mainly in the testicles. While testosterone helps the body develop male characteristics during puberty, it also plays a central role in maintaining healthy sexual function, energy, mood, and body composition in adult males.
Low testosterone, or “Low T,” is a condition that affects as many as 13 million American men1. It occurs when the body is unable to produce sufficient quantities of testosterone. The medical name for low testosterone is hypogonadism. It can be caused by many factors, including certain genetic conditions, testicular damage or infection, and exposure to toxins, radiation, or chemotherapy2. Low testosterone is often associated with aging. The goal of testosterone replacement therapy is to return testosterone levels into the normal range and relieve symptoms.
Important Safety Information: Testim® is a prescription medicine used to treat hypogonadism, a medical condition that occurs when the body does not make enough testosterone. Only your doctor can decide if Testim is right for you. Testim should not be used by men with known or suspected cancer of the prostate or breast. Testim has not been approved or evaluated for use in women, and must not be used by women. Testosterone may cause fetal harm. Pregnant and nursing women, as well as children, should avoid skin contact with Testim application sites in men. In controlled clinical studies of Testim, the most common side effects reported were redness/irritation at the application site (4%) and above normal red blood cell count (2%).
Indication: Testim® is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.
Important Safety Information: Androgens are contraindicated in men with cancer known or suspected of the breast or prostate. Testim is not indicated for use in women, has not been evaluated for use in women, and must not be used in women. Testosterone may cause fetal harm. Pregnant and nursing women, as well as children, should avoid skin contact with Testim application sites. Geriatric patients treated with androgens may be at greater risk of prostatic hyperplasia and prostatic carcinoma.
Adverse Events: Adverse events reported at a level greater than 1% that were possibly or definitely related to the use of Testim in controlled clinical trials (N=304) across all dose groups were application site reaction (4%) and increase in hematocrit/hemoglobin (2%).